Yacia Benn AI
About Yacia Benn AI
Yacia Benn AI is the Vice President and Head of Worldwide Medical Oncology Disease Strategy & Opdivo at Bristol Myers Squibb, with extensive experience in medical affairs and clinical development across multiple regions.
Title
Yacia Benn AI currently serves as the Vice President, Head Worldwide Medical Oncology Disease Strategy & Opdivo at Bristol Myers Squibb in New Jersey, United States.
Company
Yacia Benn AI is associated with Bristol Myers Squibb, a well-known pharmaceutical company, where she has held various leadership roles in the medical and oncology domains.
Education and Expertise
Yacia Benn AI possesses a Doctor of Medicine (M.D.) degree from Faculté de Medecine Alger, specialized in Virology, Immunology, and Infectious Diseases. She further honed her skills with a focus on Pharmaceutics and Drug Design by completing the Young Manager Program at INSEAD.
Professional Background
Yacia Benn AI has an extensive professional background with Bristol Myers Squibb. She has progressed through roles such as Executive Director, Head WW Medical Markets Oncology; Executive Director, WW Medical lead GI tumors; and Medical Director roles specializing in oncology and virology across different global markets including the Middle East, Africa, India, and Europe.
Leadership in Oncology
In her current role, Yacia Benn AI leads the strategic development and implementation of medical oncology disease strategies globally. She played a crucial role in the global launch and market expansion of Opdivo, one of the leading immuno-oncology drugs.